Legal Representation
Attorney
Lynn E. Rzonca
USPTO Deadlines
Application History
12 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Sep 14, 2025 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| Sep 14, 2025 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| Sep 14, 2025 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| Aug 20, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Aug 20, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Aug 20, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| May 20, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| May 20, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| May 20, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| May 14, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| May 11, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Nov 20, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Medical and scientific research in the field of behavioral, analgesic, psychiatric, neuroprotective, circadian, cognitive and motor capacities on normal, mutated, drug-treated or aged animals; medical testing in the field of preclinical research; medical testing in the field of drug discovery research; medical testing in the field of central nervous system research; pharmacological phenotype testing; Research services and scientific developments in the field of drug discovery, psychiatric, and central nervous system research utilizing apparatus for measuring and accessing motor responses on normal, drug-treated or aged animals; Medical and scientific research, namely, pharmaceutical and biotechnological research of human disorders using animal models, specifically, screening and testing of chemical compounds for therapeutic or toxic effects, and capturing, quantifying, processing and electronic data storage of information on behavioral and physiological changes in animal subjects
First Use Anywhere:
Nov 11, 2023
First Use in Commerce:
Nov 11, 2023
Additional Information
Design Mark
The mark consists of the stylized letters "P", "G" and "I" combined together which appears to the left of the stylized mark "PsychoGenics." The phrase "Transforming CNS Discovery" appears below.
Color Claim
Color is not claimed as a feature of the mark.
Pseudo Mark
PSYCHO GENICS INC PSYCHO GENICS TRANSFORMING CNS DISCOVERY
Other
PSYCHOGENICS has become distinctive of the goods/services as evidenced by the ownership on the Principal Register for the same mark for sufficiently similar goods/services of active U.S. Registration No(s). 2563883 and 5880034
Classification
International Classes
042